SCHEMBL584498

SCHEMBL584498

OC(OCc1ccccc1)(OCc1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
TSHR P16473 2/20 0.46
IDO1 P14902 1/20 0.43
CHRM3 P20309 4/20 0.42
SLC6A2 P23975 3/20 0.42
SLC6A3 Q01959 3/20 0.42
CHRM2 P08172 2/20 0.42
CHRM1 P11229 2/20 0.42
PDE4A P27815 1/20 0.42
SLC6A4 P31645 1/20 0.42
OPRM1 P35372 1/20 0.42
PTPN1 P18031 1/20 0.41
AGXT P21549 1/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 2/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7723438 0.83 TSHR (0.52) CYP2C19CYP1A2CYP2C9TSHRIDO1
SCHEMBL3955750 0.83 CYP2C19 (0.48) CYP2C19CYP1A2CYP2C9TSHRIDO1
SCHEMBL603883 0.79 CYP1A2 (0.45) CYP2C19CYP1A2CYP2C9TSHRIDO1
SCHEMBL18094635 0.77 TSHR (0.50) CYP2C19CYP1A2CYP2C9TSHRIDO1
SCHEMBL1092597 0.77 KIF11 (0.54) CYP2C19CYP1A2CYP2C9TSHRIDO1
SCHEMBL10659412 0.76 ALDH1A1 (0.44) CYP2C19CYP1A2CYP2C9TSHRSLC6A2
SCHEMBL7427682 0.76 TSHR (0.48) CYP2C19CYP1A2CYP2C9TSHRIDO1
SCHEMBL1356758 0.76 TSHR (0.48) CYP2C19CYP1A2CYP2C9TSHRIDO1
SCHEMBL11355373 0.76 ALDH1A1 (0.41) CYP2C19CYP1A2CYP2C9CHRM3CHRM2
SCHEMBL7943850 0.75 KDM4E (0.46) CYP2C19CYP1A2CYP2C9TSHRIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118112898-A Photoresist stripping liquid and application thereof 芝普企业股份有限公司 2024-05-31 CN claimed
CN-118112898-A Photoresist stripping liquid and application thereof 芝普企业股份有限公司 2024-05-31 CN disclosed
EP-2417119-B1 NO-CARRIER-ADDED NUCLEOPHILIC ÝF-18¨FLUORINATION OF AROMATIC COMPOUNDS UNIV CALIFORNIA (US) 2016-12-21 EP disclosed
US-8742139-B2 No-carrier-added nucleophilic [F-18] fluorination of aromatic compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-06-03 US disclosed
US-20120123120-A1 No-Carrier-Added Nucleophilic [F-18] Fluorination of Aromatic Compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-05-17 US disclosed
EP-2417119-A2 NO-CARRIER-ADDED NUCLEOPHILIC ÝF-18¨FLUORINATION OF AROMATIC COMPOUNDS The Regents of The University of California (US) 2012-02-15 EP disclosed
WO-2010117435-A2 NO-CARRIER-ADDED NUCLEOPHILIC [F-18] FLUORINATION OF AROMATIC COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-10-14 WO disclosed
EP-0311517-A2 Amide compound having glutamate receptor inhibiting activity Takeda Chemical Industries, Ltd. (JP) 1989-04-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123120-A1 No-Carrier-Added Nucleophilic [F-18] Fluorination of Aromatic Compounds SLC18A1, SLC18A2, SLC6A2 CYP2C19 241/4885CYP1A2 765/4885CYP2C9 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.